Norwegian Sovereign Wealth Fund Reduces Stake in Pharmaron by 55,200 Shares at Approximately HKD 23.63 Each

Deep News

07/28

PHARMARON (ASX: 03759) shares are under some pressure following a recent disclosure from the Hong Kong Stock Exchange.

The exchange's latest data indicates that on July 23, Norges Bank reduced its position in the contract research organization by 55,200 shares. The transaction was executed at an average price of HKD 23.6254 per share, amounting to a total consideration of approximately HKD 1.3041 million.

Following this sale, Norges Bank's total shareholding in Pharmaron now stands at roughly 21.3905 million shares, which equates to a 5.97% stake in the company.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/news/1167069371"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1167069371\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1167069371?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-28 07:40","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1167069371","market":"sh","top_or_hot":-1,"title":"Norwegian Sovereign Wealth Fund Reduces Stake in Pharmaron by 55,200 Shares at Approximately HKD 23.63 Each","media":"Deep News","content":"<p><b>PHARMARON (ASX: 03759)</b> shares are under some pressure following a recent disclosure from the Hong Kong Stock Exchange.<br><br>The exchange's latest data indicates that on July 23, Norges Bank reduced its position in the contract research organization by 55,200 shares. The transaction was executed at an average price of HKD 23.6254 per share, amounting to a total consideration of approximately HKD 1.3041 million.<br><br>Following this sale, Norges Bank's total shareholding in Pharmaron now stands at roughly 21.3905 million shares, which equates to a 5.97% stake in the company.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Norwegian Sovereign Wealth Fund Reduces Stake in Pharmaron by 55,200 Shares at Approximately HKD 23.63 Each</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNorwegian Sovereign Wealth Fund Reduces Stake in Pharmaron by 55,200 Shares at Approximately HKD 23.63 Each\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1039043262\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/8296859682db4b478146245e72de1922);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Deep News </p>\n<p class=\"h-time smaller\">2026-07-28 07:40</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p><b>PHARMARON (ASX: 03759)</b> shares are under some pressure following a recent disclosure from the Hong Kong Stock Exchange.<br><br>The exchange's latest data indicates that on July 23, Norges Bank reduced its position in the contract research organization by 55,200 shares. The transaction was executed at an average price of HKD 23.6254 per share, amounting to a total consideration of approximately HKD 1.3041 million.<br><br>Following this sale, Norges Bank's total shareholding in Pharmaron now stands at roughly 21.3905 million shares, which equates to a 5.97% stake in the company.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ENOR","symbol_name":"iShares MSCI Norway ETF","start_time":0,"source_url":"","article_id":"1167069371","we_media_id":"1039043262","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1167069371","pubTimestamp":1785195627,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Deep News","introduction":"Global Stock Market Deep Analysis","home_visible":1,"id":"1039043262","head_image":"https://community-static.tradeup.com/news/8296859682db4b478146245e72de1922"},"summary":"PHARMARON (ASX: 03759) shares are under some pressure following a recent disclosure from the Hong Kong Stock Exchange.The exchange's latest data indicates that on July 23, Norges Bank reduced its...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"300759":"康龙化成","ENOR":"iShares MSCI Norway ETF","BK0216":"研究试验","BK1141":"生命科学工具和服务","EWH":"香港ETF-iShares MSCI","03759":"康龙化成","BK1576":"医药外包概念"},"translate_title":"挪威主权财富基金以每股约23.63港元减持康龙化成55,200股股份","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"300759":1,"03759":1,"ENOR":1,"EWH":1},"content_text":"PHARMARON (ASX: 03759) shares are under some pressure following a recent disclosure from the Hong Kong Stock Exchange.The exchange's latest data indicates that on July 23, Norges Bank reduced its position in the contract research organization by 55,200 shares. The transaction was executed at an average price of HKD 23.6254 per share, amounting to a total consideration of approximately HKD 1.3041 million.Following this sale, Norges Bank's total shareholding in Pharmaron now stands at roughly 21.3905 million shares, which equates to a 5.97% stake in the company.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"shareholding","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}